Aarti Pharmalabs Profit & Loss Annual

Trade
BSE: 543765 | NSE: - | ISIN: INE0O4V01010 | Sector: Iron & Steel
46.90 0.00 (0.00%)Updated : 17 MAY 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Revenue 91.8148.8824.1231.65
Total Revenue 91.8148.8824.1231.65
Costof Revenue Total 73.8812.296.419.14
Gross Profit 17.9336.5917.7122.52
Selling/ General/ Admin Expenses Total 3.552.381.240.99
Depreciation/ Amortization 2.101.511.451.38
Other Operating Expenses Total 1.9820.609.8418.76
Total Operating Expense 81.5136.7818.9530.27
Operating Income 10.3112.105.171.38
Interest Inc( Exp) Net- Non- Op Total -6.77-11.99-17.43-17.45
Other Net 0.000.000.000.00
Net Income Before Taxes 9.6310.903.42-0.36
Provisionfor Income Taxes 2.113.440.75-0.02
Net Income After Taxes 7.527.452.67-0.34
Net Income Before Extra Items 7.527.452.67-0.34
Net Income 7.527.452.67-0.34
Total Adjustmentsto Net Income -0.14-0.000.00
Income Availableto Com Excl Extra Ord 7.517.452.67-0.33
Income Availableto Com Incl Extra Ord 7.517.452.67-0.33
Diluted Net Income 7.517.452.67-0.33
Diluted Weighted Average Shares 0.951.221.221.22
Diluted EPS Excluding Extra Ord Items 7.946.092.18-0.27
DPS- Common Stock Primary Issue 0.50---
Diluted Normalized EPS 7.946.092.18-0.27
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,502.20+57.00(2.33%)
952.95+7.20(0.76%)
2,504.50-9.95 (-0.40%)
12,600.00-43.85 (-0.35%)
HomeMarketsPremiumFor youGet App